MindBio Therapeutics - AI voice analytics for real-time drug and alcohol intoxication detection

Saint Petersburg, Florida Mar 5, 2026 (Issuewire.com) - Disseminated on behalf of MindBio Therapeutics

What This Company Does

MindBio built an AI model trained on 50+ million voice data points from clinical drug and alcohol trials. The technology analyzes short voice samples to predict intoxication levels in real time, no hardware, no blood draw, no breathalyzer. The consumer app (Booze AI) launched in 2025 as the first voice-activated blood alcohol estimator on smartphones. The company is now developing enterprise versions for workplaces, mining, law enforcement, and healthcare.

Why It Matters

Traditional impairment testing is invasive, expensive, and episodic. Voice-based detection is software-only, scalable, and can be deployed remotely. If the accuracy holds in commercial environments, this addresses massive markets: workplace safety compliance, road safety, addiction treatment monitoring, and insurance risk. The company announced on February 18, 2026 that it is building a dedicated Edge AI hardware device for the mining sector, with Chile as its first target market and prototype completion expected Q2 2026. Each device would carry recurring software revenue.

Leadership Highlights

Chairman Gavin Upiter founded Generic Health (sold to Lupin Pharmaceuticals), served as Australian CEO of Amneal Pharmaceuticals (NYSE: AMRX), and held executive roles at Bristol-Myers Squibb and Slade Health. CEO Justin Hanka is an investment banker and co-founder who remains a significant shareholder.

Recent Milestones

Date

 More On Iglobalupdate ::

•   Launching a New Era of Packaging via Modern Technology: The Box Zilla
•   Odion Menswear Redefines Modern Style with Premium Quality and Purpose-Driven Fashion
•   Cirface to Deliver a Two-Day Bilingual 'Asana On Tour' Training Workshop in Montreal
•   Sam Altman's Merge Labs Secures $252M Seed Led by OpenAI: BCI Progress in the Era of Unified AI Tools Like AICC
•   Pro-Line Trailers to Exhibit at MDA Car Show 2026

Event

Jan 2025

Discovered speech-based intoxication detection from clinical trial data; LOI to acquire Life AI Corp

Mar 2025

Closed acquisition of Life AI Corp and Booze AI application

May 2025

Completed Booze AI software development; prepared for consumer launch

Nov 2025

400:1 share consolidation approved and completed via CSE

Jan 2026

Listed on OTCQB; launched US showcase of voice AI detection tech

Feb 2026

Announced Edge AI hardware platform for mining; initiated Chile operations

For more information visit: https://mindbiotherapeutics.com

https://www.tradingview.com/news/reuters.com%2C2026-02-18%3Anewsml_Tnw971MHZ%3A0-mindbio-advances-large-scale-deployment-of-voice-intoxication-detection-through-integrated-edge-ai-hardware-software-platform/

Sponsored Article
by Street Scope Media, LLC
Communicated Disclaimer